Abstract
<i>Objective</i>: To analyze discrepancy between cTNM and pTNM in patients with squamous cell carcinoma of oral cavity. <i>Study design</i>: Cross-sectional study. <i>Setting & Duration</i>: Cases of OSCC treated in Oral and Maxillofacial Surgery Department, Allied Hospital Faisalabad from December 2017 to November 2020 were included in the study. <i>Methodology</i>: Total 80 patients with biopsy proven OSCC were enrolled in the study. cTNM staging was based on clinical examination and CT/MRI. Primary tumor excision along with neck dissection was done in all patients. Postoperatively pTNM staging was done and compared to cTNM. The clinical, radiological and histopathological lymph node status of patients were compared. <i>Results</i>: Among 80 patients, male to female ratio was 1.6:1. The mean of age was 50.2±10.2 years. The most common site in our center was the lateral border of the tongue. The total coincidence rate between clinical T-stage and pathological T-stage was 57.5%. On comparison between the clinical and pathological N-stage the total coincidence rate was 40%. The total coincidence rate between cTNM and pTNM was 35% and the p-value was insignificant (p>0.05). The sensitivity of CT/MRI for N-stage was 53.3% and specificity was 60% and positive predictive value (PPV) was 53.3% and negative predictive value (NPV) was 60%. <i>Conclusion</i>: Disparity between cTNM and pTNM of OSCC exits that could affect the treatment planning and prognosis.
Highlights
Oral squamous cell carcinoma (OSCC) is the 8th most common cancer in the world [1]
Accurate TNM staging is important for the treatment of oral carcinoma as it helps in the proper treatment planning and predicting the prognosis [17]
Metastasis to cervical lymph nodes can be determined on computed tomography (CT) and magnetic resonance imaging (MRI) but histopathology is gold standard
Summary
Oral squamous cell carcinoma (OSCC) is the 8th most common cancer in the world [1]. It accounts for 2-4% of all the cancers in the world and 10% of all cancers in Pakistan [2]. Each year 650,000 new cases and 350,000 deaths are reported globally, due to oral cancer [3]. Male to female ratio is 2:1 [4]. Mortality and morbidity in males is 6.6/100,000 and 3.1/100,000 and in females is 2.9/100,000 and 1.4/100,000 respectively. The reported 5-year survival is 4050% [2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Clinical Oral and Maxillofacial Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.